Balance Sheet for OncoCyte Corporation (OCX)

$ 2.22   0.02 (+0.91%) Volume: 495.29k 8:00 PM EDT 20-Sep-2019
After Hours:  $ 2.2201   0.0001 (+0.00%) Volume: 9.9k 4:01 PM EDT 20-Sep-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 8,034 7,600 10,174 7,996 257
Restrictable Cash - - - - -
Marketable Securities 428 760 2,237 2,541 3,280
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 180 168 285 388 114
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 8,642 8,528 12,696 10,925 3,651
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment 1,562 1,479 1,007 750 251
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 1,562 1,479 1,007 750 251
Gross Fixed Assets 1,562 1,479 1,007 750 251
Accumulated Depreciation (948) (657) (319) (174) (133)
Net Fixed Assets 614 822 688 576 118
Intangibles 686 746 988 1,230 1,472
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - 883 1,115
Other Non-Current Assets - - 75 - -
Total Non-Current Assets 876 1,688 1,751 1,806 1,590
Total Assets 9,518 10,216 14,447 12,731 5,241
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 2,267 2,274 3,276 1,132 6,033
Short Term Debt 1,185 1,138 202 472 5,889
Notes Payable - - - - -
Accrued Expenses 806 406 248 857 135
Accrued Liabilities 806 406 248 857 135
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 1,303 636 549 (1,030) (6,857)
Total Current Liabilities 5,561 4,454 4,275 2,314 6,315
Long Term Debt 534 1,359 310 - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - - (3,300) -
Minority Interest - - - - -
Capital Lease Obligations 187 289 310 - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 534 1,359 310 - -
Total Liabilities 6,095 5,813 4,585 2,314 6,315
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 3,423 4,403 9,862 10,417 (1,074)
Common Par - - - - -
Additional Paid in Capital 74,742 59,968 45,818 34,901 15,147
Cumulative Translation Adjustments - - - - -
Retained Earnings (71,319) (54,677) (35,302) (24,134) (15,399)
Treasury Stock - - - - -
Other Equity Adjustments - (888) (654) (350) (822)
Total Capitalization 3,770 5,473 9,862 13,717 (1,074)
Total Equity 3,423 4,403 9,862 10,417 (1,074)
Total Liabilities & Shareholder's Equity 9,518 10,216 14,447 12,731 5,241
Cash Flow (16,331) (20,011) (11,169) (8,735) (4,986)
Working Capital 3,081 4,074 8,421 8,611 (2,664)
Free Cash Flow (11,680) (13,476) (7,628) (4,729) (1,173)
Invested Capital 3,770 5,473 9,862 10,417 (1,074)
Shares Outstanding - Common Class Only 40,664 31,452 28,737 25,391 -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 40,664 31,452 28,737 25,391 25,391
Total Common Shares Outstanding 40,664 31,452 28,737 25,391 -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 37,850 30,195 26,529 21,009 25,391
Diluted Weighted Shares Outstanding 37,850 30,195 26,529 21,009 25,391